Navigation Links
Timely Analysis of Pain Relief Costs and Outcomes Finds Disproportionate Risks for Seniors
Date:2/28/2013

MADISON, Tenn., Feb. 28, 2013 /PRNewswire/ -- A recently completed study finds that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) pose costly dangers for senior citizens. "Actuarial Cost Profile of Pain Management Using Prescription NSAIDs" documents the fast-growing financial toll linked to NSAID toxicity and side effects.

Vireo Systems, Inc., which specializes in safe, effective pain relief research and products, commissioned an independent researcher to conduct the study. Vireo's priority was to explore quantitative statistics from a cross-section of published literature on the role of prescription NSAIDs for pain management. Among the findings:

  • Nearly 33 million people including 13.8 million seniors (65+) regularly use NSAIDs for treating pain and inflammation.
  • Gastrointestinal (GI) issues, renal problems and cardiac complications are the top-three most-cited side effects -- although others exist, which further escalates healthcare costs.
  • Seniors over 75 years old who regularly use NSAIDs are six times more likely to experience toxic side effects than other users.
  • The average hospitalization cost for someone suffering from common NSAID-associated side effects is $15,000-$20,000.
  • By 2030, seniors will represent approximately half of all NSAID users and will be responsible for two-thirds of the added costs for all NSAID side effects.

The study also reports that doctors write 70 million NSAID prescriptions every year despite mounting evidence of disproportionate side effects in the senior community. NSAIDs are the second most commonly prescribed drugs, with antibiotics being the most common. The most active pharmaceutical ingredients in today's common NSAIDs include Naproxen, Ibuprofen, Celecoxib and Diclofenac.

In the future, aging baby boomers and rising pressure to control healthcare costs will boost demand for safe, effective NSAID alternatives. In fact, treating pain and inflammation with non-toxic, proven options is already reducing patient exposure to medical complications, lowering prescription costs, and exercising the preventative measures that are the hallmark of the new Affordable Care Act. If such solutions become the norm -- rather than the exception -- they could save an estimated $250 billion over the next 20 years and prevent millions of seniors from jeopardizing their health.

Mark Faulkner , president of Vireo Systems, stated, "Safe, non-toxic pain relievers such as AminoActiv clearly align with the future direction of medicine. As the next generation of healthcare delivery, including state health insurance exchanges and nonprofit health insurance co-ops, mobilizes toward a prevention-based model -- and physicians consider the benefits of prescribing NSAID alternatives first -- our study offers compelling support for cost-savings through greater pain management choices and a future free from NSAID side effects."

For additional information about the study, contact Mark Faulkner , 855-442-6466. 

About Vireo Systems, Inc.

Taking inspiration from one of the Latin words for "health," Vireo Systems, Inc. is the manufacturer of a number of nutraceuticals and health promotion products including AminoActiv, the #1 alternative to ibuprofen and NSAIDs. Vireo was founded in 2002 as part of a project with several university-based researchers, and today, the company's products deliver safe, effective relief for inflammation and pain. Vireo meets industry-standard good manufacturing practices as expected by the FDA, and AminoActiv safety and toxicity data have been reviewed and accepted by the FDA.

Vireo is headquartered just outside Nashville, Tenn., with a secondary facility in Plattsmouth, Neb., where it manufactures its pain relief capsules and cream. Vireo is a two-time nominee for the NEXT Award, a prestigious honor celebrating successful businesses in the Middle Tennessee Region and part of an annual recognition program sponsored by the Nashville Area Chamber of Commerce and Entrepreneurial Center.

Contact:

Mark Faulkner
President, Vireo Systems, Inc.
855-442-6466
markf@vireosystems.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Vireo Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
2. New International Survey Reveals Multiple Barriers to an Accurate and Timely Alzheimers Disease Diagnosis
3. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
4. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
5. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
6. Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse
7. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
8. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
9. Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry
10. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
11. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
Breaking Medicine News(10 mins):